Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000007

PRESIDENT AND COO sold 30,375 shares at an average $470.03 ($14,277,114)

  • PRESIDENT AND COO acquired 30,375 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Option exercise 10b5-1 +7,875 $146.03 $1,149,986 7,875 I: show line 1 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −63 $456.87 $28,783 7,812 I: show line 2 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −372 $457.92 $170,345 7,440 I: show line 3 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −377 $458.74 $172,944 7,063 I: show line 4 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −268 $459.86 $123,244 6,795 I: show line 5 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −271 $461.12 $124,963 6,524 I: show line 6 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −1,322 $463.26 $612,430 5,202 I: show line 7 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Sale 10b5-1 −1,225 $464.06 $568,468 3,977 I: show line 8 in the form
Open-market sales · 30,375 sh · avg $470.03 · $14,277,114

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-20 Option exercise · Stock Options 10b5-1 −7,875 36,565 I: show line 20 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-26 Option exercise · Stock Options 10b5-1 −14,625 53,250 I: show line 21 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-26 Option exercise · Stock Options 10b5-1 −7,875 28,690 I: show line 22 in the form
Loading xslF345X05/primarydocument.xml…